Literature DB >> 12061218

Inflammatory response in open and laparoscopic cholecystectomy.

G Di Vita1, C Sciumè, S Milano, R Patti, G L Lauria, G Di Bella, R Caruso, P Leo, E Cillari.   

Abstract

The modifications of IL-6. CRP, ceruloplasmin, alpha 1 antitrypsin, fibrinogen, transferrin, albumin and leukocytes counts have been evaluated after traditional open cholecystectomy (OC) or laparoscopic cholecystectomy (LC). Forty-two patients were included in this study, 20 underwent to OC and 22 underwent to LC. Serum samples were performed before surgery and at distance of 6, 24, 48 and 168 hours. The results show a more significant increase in acute phase inflammatory response after OC compared with LC as attested by highest values of leukocytosis, IL-6, CRP, fibrinogen and alpha 1 antitrypsin and lower levels of albumin. In conclusion, after LC, the phase acute response is attenuate and it can explain the reduced period of convalescence of patients treated with LC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12061218

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  3 in total

1.  Changes of inflammatory mediators in obese patients after laparoscopic cholecystectomy.

Authors:  Gaetano Di Vita; Rosalia Patti; Fausto Famà; Carmela Rita Balistreri; Giuseppina Candore; Calogero Caruso
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Effects of open versus laparoscopic nephrectomy techniques on oxidative stress markers in patients with renal cell carcinoma.

Authors:  Celestyna Mila-Kierzenkowska; Alina Woźniak; Tomasz Drewa; Bartosz Woźniak; Michał Szpinda; Ewa Krzyżyńska-Malinowska; Paweł Rajewski
Journal:  Oxid Med Cell Longev       Date:  2013-02-24       Impact factor: 6.543

3.  28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study.

Authors:  Jan Ulrych; Tomas Kvasnicka; Vladimir Fryba; Martin Komarc; Ivana Malikova; Filip Burget; Radka Brzezkova; Jan Kvasnicka; Zdenek Krska; Jan Kvasnicka
Journal:  BMC Surg       Date:  2016-04-06       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.